Showing results (1-10 of 3,229) with videos related to
Sort By:
Pageof 323
Drug Discovery Today|May 18, 2024
Best practices for machine learning in antibody discovery and developmentLeonard Wossnig, Norbert Furtmann, Andrew Buchanan, et al.Mabs|April 10, 2025
How to think about designing smart antibodies in the age of genAI: integrating biology, technology, and experienceAndrew Buchanan, Eric Bennett, Rebecca Croasdale-Wood, et al.Mini Reviews in Medicinal Chemistry|February 20, 2015
Structural and Modeling Studies on ecto-5'-nucleotidase Aiding in Inhibitor DesignNorbert Furtmann, Jurgen BajorathBioorganic & Medicinal Chemistry|September 10, 2013
Evaluation of molecular model-based discovery of ecto-5'-nucleotidase inhibitors on the basis of X-ray structuresNorbert Furtmann, Jürgen BajorathPhysical Review Letters|February 27, 2018
Quantum Linear System Algorithm for Dense MatricesLeonard Wossnig, Zhikuan Zhao, Anupam PrakashProteins|March 4, 2025
Investigating Local Sequence-Structural Attributes of Amyloidogenic Light Chain Variable DomainsPuneet Rawat, R Prabakaran, Divya Sharma, et al.Journal of Medicinal Chemistry|July 23, 2014
Current compound coverage of the kinomeYe Hu, Norbert Furtmann, Jürgen BajorathJournal of Medicinal Chemistry|July 24, 2014
Comprehensive analysis of three-dimensional activity cliffs formed by kinase inhibitors with different binding modes and cliff mapping of structural analoguesNorbert Furtmann, Ye Hu, Jürgen BajorathJournal of Chemical Information and Modeling|May 23, 2012
Systematic identification and classification of three-dimensional activity cliffsYe Hu, Norbert Furtmann, Michael Gütschow, et al.Chemical Biology & Drug Design|June 23, 2015
Identification of Interaction Hot Spots in Structures of Drug Targets on the Basis of Three-Dimensional Activity Cliff InformationNorbert Furtmann, Ye Hu, Michael Gütschow, et al.Pageof 323